Latest News & Features
Americas
A biotechnology company that licenses a patent related to the gene-editing technology CRISPR/Cas9 has raised more than $94 million in its initial share offering. 10 February 2016
Asia
India’s weak intellectual property enforcement regime and its vague grounds centring on compulsory licences for drugs are reasons it should remain on the “Priority Watch List” in this year’s "Special 301 Report", a pharmaceutical industry association has argued. 9 February 2016
Big Pharma
Law firm Carpmaels & Ransford has hired David Wilson and Jake Marshall as partners in the firm’s patent litigation and life sciences practices. 9 February 2016
Americas
Supernus Pharmaceuticals has defeated Actavis in a patent infringement dispute centring on epilepsy drug Oxtellar XR. 8 February 2016
Americas
The US Court of Appeals for the Federal Circuit has revived medical device company TriReme Medical’s attempt to correct the record of three patents related to catheters. 8 February 2016
Americas
A man who sold and imported counterfeit drugs, including Viagra and Diazepam, into the US has appeared in court. 8 February 2016
Americas
The chief executive of biotechnology Twist Bioscience has been accused of stealing trade secrets belonging to her former employer. 5 February 2016
Asia
India-based vaccines and biotherapeutic manufacturer Bharat Biotech has said it has filed the first patent for a vaccine for the Zika virus. 5 February 2016
Americas
AstraZeneca has predicted a dip in revenue this year after it loses patent exclusivity on its anti-cholesterol drug Crestor. 4 February 2016
Big Pharma
The Pharmaq v Intervet SPC decision leaves open the question of just how similar to the authorised active ingredient an infringing generic product needs to be. Sam Bailey of Mewburn Ellis reports. 4 February 2016